Antianxiety medications for the treatment of complex agoraphobia: pharmacological interventions for a behavioral condition

Código QR

Antianxiety medications for the treatment of complex agoraphobia: pharmacological interventions for a behavioral condition

Giampaolo Perna1-3, Silvia Dacc&ograve;2, Roberta Menotti2, Daniela Caldirola21Department of Psychiatry and Neuropsychology, Faculty of Health, Medicine and Life Sciences, University of Maastricht, Maastricht, the Netherlands; 2Department of Clinical Neuroscience, San Benedetto Hospital, Her...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Perna G, Dacc&ograve; S, Menotti R, Caldirola D
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2011
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/8dbcfc5c308b419b93df62df99ca8375
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Toward a personalized therapy for panic disorder: preliminary considerations from a work in progress
por: Caldirola D, et al.
Publicado: (2019)

Arm swing responsiveness to dopaminergic medication in Parkinson’s disease depends on task complexity
por: Elke Warmerdam, et al.
Publicado: (2021)

Pharmacological management of panic disorder
por: Carlo Marchesi
Publicado: (2008)

Aripiprazole: from pharmacological profile to clinical use
por: Di Sciascio G, et al.
Publicado: (2015)

Aripiprazole in the treatment of Huntington&rsquo;s disease: a case series
por: Andrea Ciammola, et al.
Publicado: (2008)

Behavioral symptoms related to cognitive impairment
por: Dillon C, et al.
Publicado: (2013)

Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
por: Alvarez E, et al.
Publicado: (2014)

Electroencephalographic and behavioral convulsant effects of hydrobromide and hydrochloride salts of bupropion in conscious rodents
por: David C Henshall, et al.
Publicado: (2009)

Effect of 17&beta;-estradiol on olfactory bulbectomy-induced oxidative stress and behavioral changes in rats
por: Inmaculada Tasset, et al.
Publicado: (2008)

A systematic review on exercise and training-based interventions for freezing of gait in Parkinson’s disease
por: Moran Gilat, et al.
Publicado: (2021)

Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism
por: Jean-Michel Azorin, et al.
Publicado: (2010)

Reasons for reoperation after epilepsy surgery: a review based on a complex clinical case with three operations
por: Jos&eacute; F T&eacute;llez-Zenteno, et al.
Publicado: (2010)

Genetic and environmental factors in Alzheimer’s and Parkinson’s diseases and promising therapeutic intervention via fecal microbiota transplantation
por: Hui Wang, et al.
Publicado: (2021)

Neonatal bilateral lidocaine administration into the ventral hippocampus caused postpubertal behavioral changes: An animal model of neurodevelopmental psychopathological disorders
por: Vanessa Blas-Valdivia, et al.
Publicado: (2008)

A comparison of complex sleep behaviors with two short-acting Z-hypnosedative drugs in nonpsychotic patients
por: Chen LF, et al.
Publicado: (2013)

Neutrophil–lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy
por: Demir S, et al.
Publicado: (2015)

Secondary prevention medication persistence and prognosis of acute ischaemic stroke or transient ischaemic attack
por: Lei Zhang, et al.
Publicado: (2021)

Cognitive behavioral therapy for insomnia in Parkinson’s disease: a case series
por: Meghan Humbert, et al.
Publicado: (2017)

Response inhibition in Parkinson’s disease: a meta-analysis of dopaminergic medication and disease duration effects
por: Peter Manza, et al.
Publicado: (2017)

Serum metabolic biomarkers for synucleinopathy conversion in isolated REM sleep behavior disorder
por: Ariadna Laguna, et al.
Publicado: (2021)

Quantitative angiographic haemodynamic evaluation of bypasses for complex aneurysms: a preliminary study
por: Junlin Lu, et al.

Imaging mass cytometry reveals generalised deficiency in OXPHOS complexes in Parkinson’s disease
por: Chun Chen, et al.
Publicado: (2021)

An innovative intervention for the treatment of cognitive impairment–Emisymmetric bilateral stimulation improves cognitive functions in Alzheimer’s disease and mild cognitive impairment: an open-label study
por: Guerriero F, et al.
Publicado: (2015)

Probable REM sleep behavior disorder is associated with longitudinal cortical thinning in Parkinson’s disease
por: Eun Jin Yoon, et al.
Publicado: (2021)

Targeting collective behaviors of transplanted retinal cells as a strategy to improve cellular integration
por: Miles Markey, et al.
Publicado: (2022)

A large pharmacy claims-based descriptive analysis of patients with migraine and associated pharmacologic treatment patterns
por: Muzina DJ, et al.
Publicado: (2011)

Pharmacological Intervention in Children with Autism Spectrum Disorder with Standard Supportive Therapies Significantly Improves Core Signs and Symptoms: A Single-Center, Retrospective Case Series
por: Alsayouf HA, et al.
Publicado: (2020)

FAST-ED scale smartphone app-based prediction of large vessel occlusion in suspected stroke by emergency medical service
por: Benedikt Frank, et al.
Publicado: (2021)

A National Survey of Self-Prescription of Beta-Blockers and Their Relation to Undiscovered Anxiety Among Medical and Pharmacological Students in Saudi Arabia
por: Alsini A, et al.
Publicado: (2021)

Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem)
por: Fereshtehnejad SM, et al.
Publicado: (2013)

Sumatriptan transdermal iontophoretic patch (NP101-Zelrix&trade;): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraine
por: Vikelis M, et al.
Publicado: (2012)

Pharmacological treatment of negative symptoms in schizophrenia: update and proposal of a clinical algorithm
por: Cerveri G, et al.
Publicado: (2019)

Behavior management approach for agitated behavior in Japanese patients with dementia: a pilot study
por: Sato J, et al.
Publicado: (2012)

Correction to: Normalization of magnesium deficiency attenuated mechanical allodynia, depressive-like behaviors, and memory deficits associated with cyclophosphamide-induced cystitis by inhibiting TNF-α/NF-κB signaling in female rats
por: Jia-Liang Chen, et al.
Publicado: (2021)

The interventional effects of loving-kindness meditation on positive emotions and interpersonal interactions
por: He X, et al.
Publicado: (2015)

Assessing suicide management skills of emergency medical services providers before and after suicide intervention/prevention training with Lithuanian version of suicide intervention response inventory
por: Lygnugaryte-Griksiene A, et al.
Publicado: (2018)

Polypharmacy or medication washout: an old tool revisited
por: Hoffman DA, et al.
Publicado: (2011)

The role of the serotonergic system in suicidal behavior
por: Sadkowski M, et al.
Publicado: (2013)

Behavior and neuropsychiatric manifestations in Angelman syndrome
por: Karine Pelc, et al.
Publicado: (2008)

Excited delirium: Consideration of selected medical and psychiatric issues
por: Edith Samuel, et al.
Publicado: (2009)